期刊文献+

Nt-proBNP 和血钠水平与老年慢性心力衰竭患者预后的关系 被引量:3

Serum Nt-proBNP and sodium levels are correlated with major adverse cardiac and cerebral events in elderly patients with chronic heart failure
下载PDF
导出
摘要 目的探讨 N 末端脑利钠肽原(Nt-proBNP)和血钠水平与老年慢性心力衰竭(CHF)患者预后的关系.方法以老年 CHF 患者为研究对象,随访1年,根据随访期间是否发生心血管事件分为心血管事件组(65例)和非心血管事件组(50例).采用双抗夹心免疫荧光法测定两组患者血浆 Nt-proBNP 水平,常规测定电解质、生化、血常规、血管紧张素原、肾素、血管紧张素Ⅱ和醛固酮水平,比较两组间的差异.并采用 Lgistic 回归分析探讨心血管事件的危险因素.结果心血管事件组 Nt-proBNP 明显高于非心血管事件组,血钠明显低于非心血管事件组,差异均有统计学意义(均 P〈0.01).Nt-proBNP 与血钠水平呈显著负相关(r=-0.865,P〈0.01).Nt-proBNP 及血钠与心血管事件明显相关(P〈0.05或0.01),左室舒张末期内径、左室射血分数、年龄均与心血管事件无明显相关(P〉0.05).结论 Nt-proBNP 是老年 CHF 患者心血管事件的独立危险因素,但受心室大小和 LVEF 影响不大,可能与低钠血症有关. : Objective To investigate the correlation of serum N-terminal-pro-brain natriuretic peptide (Nt-proBNP) and sodium levels with major adverse cardiac and cerebral events (MACCE) in patients with chronic heart failure (CHF). Methods One hundred and fifteen elderly patients with CHF were included in the study. Patients were followed up for 1 year and the inci-dence of MACCE was recorded. The blood Nt-proBNP, electrolytes, angiotensinogen, renin, angiotensin II and aldosterone levels were measured along with blood routine and blood biochemistry on the admission. Logistic regression analysis and survival analysis were applied for the risk factors of MACCE. Results During the 1-y fol ow-up period MACCE developed in 65 cases. The Nt-proBNP level in the MACCE group (n=65) was significantly higher than that in non-MACCE group (n=50)(P〈0.01). The Nt-proBNP was negatively correlated with serum sodium level(r=-0.865, P〈0.01). Nt-proBNP was positively and serum sodium was negatively correlated with MACCE, while LVEDD, LVEF and age were not correlated with MACCE. Conclusion Nt-proBNP is an independent risk factor of MACCE in elderly patients with CHF. Nt-proBNP level may be related to the decreased level of serum sodium, not the LVEDD or LVEF.
出处 《浙江医学》 CAS 2012年第23期1880-1882,1900,共4页 Zhejiang Medical Journal
关键词 心力衰竭 N末端脑利钠肽原 血钠 预后 老年 Chronic heart failure N-terminal-pro-brain natriuretic peptide Serum sodium Prognosis Aged
  • 相关文献

参考文献12

  • 1赵丽,吴学思,韩智红,胡荣,吕强.B型利钠肽检测对心力衰竭患者的临床评估[J].中华心血管病杂志,2004,32(1):51-52. 被引量:164
  • 2Kuster G M,Tanner H,Printzen G. B-type natriuretic pep-tide for diagnosis and treatment of congestive heart failure[J].Swiss Medical Weekly,2003.623-631.
  • 3邵健智,王齐增,朱玲军.N末端脑利钠肽原对高龄慢性心力衰竭患者长期预后影响的临床研究[J].中国全科医学,2011,14(27):3083-3085. 被引量:10
  • 4Parrinel o G,Di Pasquale P,Licata G. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure[J].Journal of Cardiac Failure,2009.864-873.
  • 5Yeo K T,Wu A H,Apple F S. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay[J].Clinica Chimica Acta,2003.107-115.
  • 6汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 7Mair J,Gerda F,Renate H. Head-to-head comparison of B-type natriuretic peptide(BNP)and NT-proBNP in daily clinical practice[J].International Journal of Cardiology,2008.244-246.
  • 8Raymond I,Groenning B,Hildebrandt P. The influence of age,sex and other variables on the plasma level of N-terminal pro-brain natriuretic peptide in a large sample of the general population[J].British Medical Journal,2003.745-751.
  • 9Bettencourt P,Frioes F,Azevedo A. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure[J].International Journal of Cardiology,2004.45-48.
  • 10Squire I B,O'Brien R J,Demme B. N-terminal pro-atrial natriuretic peptide(N-ANP)and N-terminal pro-B-type natri-uretic peptide(N-BNP)in the prediction of death and heart failure in unselected patients fol owing acute myocardial in-farction[J].Clinical Science,2004.309-316.

二级参考文献24

  • 1Cai B,Wang L,Liu J,et al.N-terminal pro-Brain natriuretic peptide as a useful biomarker for monitoring prognosis in patients with cardiac valve replacement[J].J Clin Lab Anal,2011,25(3):149-155.
  • 2Wannamethee SG,Welsh P,Lowe GD,et al.N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease[J].J Am Coll Cardiol,2011,58(1):56-64.
  • 3Dickstein K,Cohen-SoLd A,Filippatos G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:The Task Force for the Diagnosis and Treatment of Acute and Chnmic Heart Failure 2008 of the European Society of Cardiology[J].Eur Heart J,2008,29(19):2388-2442.
  • 4Januzzi JL Jr,Camargo CA,Anwaruddin S,et al.The N-terminal pro-BNP investigation of dyspnea in the emergency department(PRIDE) study[J].Am J Cardiol,2005,95(8):948-954.
  • 5Franke J,Frankenstein L,Schellberg D,et al.Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?[J].Clin Res Cardiol,2011,7(16):1254-1256.
  • 6Richard MA,Nicholls GM,Yandle TG,et al.Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin:new neurohormonal predictors of left ventricular function and prognosis aftermyocardial infarction[J].Circulation,1998,97:1921-1929.
  • 7Bazzino O,Fuselli JJ,Botto F,et al.Relative value of N-terminal probrain natriuretic peptide,TIMI risk score,ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes[J].Eur Heart J,2004,25:859-866.
  • 8Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department(PRIDE) study. Am J Cardiol.2005 .95 :948-954.
  • 9Pemberton C J, Yandle TG, Radenmker MT, et al. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload. Am J Physiol, 1998, 275:1200-1208.
  • 10Mancia G. Neurohumoral activation in congestive heart failure. Am Heart J, 1990,120:1532-1537.

共引文献239

同被引文献35

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部